Comparison of echinocandin antifungals

por Eschenauer, Gregory, DePestel, Daryl D, Carver, Peggy L
Publicado 2007

1450. Frequency of Carbapenem-resistant Pseudomonas aeruginosa Among Respiratory Pathogens Impacts First-Line Beta-Lactam Susceptibility: Potential Role for Ceftolozane/Tazobactam...

por Klinker, Kenneth, DePestel, Daryl, Motyl, Mary, DeRyke, C Andrew
Publicado 2020

1587. Activity of Ceftolozane/Tazobactam against Gram-Negative Isolates from Lower Respiratory Tract Infections – SMART United States 2018

por Lob, Sibylle, Hackel, Meredith, DePestel, Daryl, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2020

597. Cross-resistance of Ceftolozane-Tazobactam and Imipenem-Relebactam Against Clinical P. aeruginosa Isolates: SMART United States 2016–2018

por Lob, Sibylle, Kazmierczak, Krystyna, DePestel, Daryl, Raddatz, Janet, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2019

718. Activity of Ceftolozane–Tazobactam and Ceftazidime–Avibactam Against Clinical P. aeruginosa Isolates Collected in United States and Canada—SMART 2018

por Lob, Sibylle, Kazmierczak, Krystyna, Raddatz, Janet, DePestel, Daryl, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Publicado 2019

Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against Pseudomonas aer...

por Shortridge, Dee, Pfaller, Michael A, Arends, S J Ryan, Raddatz, Janet, DePestel, Daryl D, Flamm, Robert K
Publicado 2019

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study

por McCann, Eilish, Srinivasan, Arjun, DeRyke, C Andrew, Ye, Gang, DePestel, Daryl D, Murray, John, Gupta, Vikas
Publicado 2018

Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms

por Klinker, Kenneth P., Hidayat, Levita K., DeRyke, C. Andrew, DePestel, Daryl D., Motyl, Mary, Bauer, Karri A.
Publicado 2021

A Combination Antibiogram Evaluation for Pseudomonas aeruginosa in Respiratory and Blood Sources from Intensive Care Unit (ICU) and Non-ICU Settings in U.S. Hospitals

por Puzniak, Laura, DePestel, Daryl D., Srinivasan, Arjun, Ye, Gang, Murray, John, Merchant, Sanjay, DeRyke, C. Andrew, Gupta, Vikas
Publicado 2019

Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of Pseudomonas aeruginosa From Patients With Respiratory Tract Infections in ICU and Non...

por Lob, Sibylle H, DePestel, Daryl D, DeRyke, C Andrew, Kazmierczak, Krystyna M, Young, Katherine, Motyl, Mary R, Sahm, Daniel F
Publicado 2021

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-I...

por Brown, Michelle L, Motsch, Johann, Kaye, Keith S, File, Thomas M, Boucher, Helen W, Vendetti, Neika, Aggrey, Angela, Joeng, Hee-Koung, Tipping, Robert W, Du, Jiejun, DePestel, Daryl D, Butterton, Joan R, Paschke, Amanda
Publicado 2020